2021 Regular Session SB 844 Enrolled

• Bill Title: Relating to the price of prescription drugs.

Catchline/Summary

Establishes Prescription Drug Affordability Board in Department of Consumer and Business Services to review prices for nine drugs and at least one insulin product, from among drugs reported to Prescription Drug Price Transparency program by prescription drug manufacturers, drugs reported by insurers in filings and insulin drugs marketed in this state, that are expected to create affordability challenges for health systems or high out-of-pocket costs for patients in Oregon based on specified criteria.

Establishes Prescription Drug Affordability Board in Department of Consumer and Business Services to review prices for prescription drug products meeting specified cost criteria. Requires board to establish upper payment limit for drugs that are or] nine drugs and at least one insulin product, from among drugs reported to Prescription Drug Price Transparency program by prescription drug manufacturers, drugs reported by insurers in filings and insulin drugs marketed in this state, that are expected to create affordability challenges for health systems and] or high out-of-pocket costs for patients in Oregon or health inequities for communities of color] based on specified criteria. Requires department, in consultation with board, to establish and assess fees against manufacturers of prescription drug products sold in Oregon for costs of carrying out duties of board.

Establishes Prescription Drug Affordability Stakeholder Council to assist board in carrying out its duties.].

• Chapter Number: Chapter 598
• Fiscal Impact: Budget Report Issued
• Revenue Impact: No Revenue Impact
• Current Location: Chapter Number Assigned